Does TOFACITINIB Cause Red blood cell sedimentation rate abnormal? 625 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 625 reports of Red blood cell sedimentation rate abnormal have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.4% of all adverse event reports for TOFACITINIB.
625
Reports of Red blood cell sedimentation rate abnormal with TOFACITINIB
0.4%
of all TOFACITINIB reports
19
Deaths
396
Hospitalizations
How Dangerous Is Red blood cell sedimentation rate abnormal From TOFACITINIB?
Of the 625 reports, 19 (3.0%) resulted in death, 396 (63.4%) required hospitalization, and 49 (7.8%) were considered life-threatening.
Is Red blood cell sedimentation rate abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 625 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Red blood cell sedimentation rate abnormal?
ETANERCEPT (1,590)
METHOTREXATE (1,445)
ABATACEPT (1,444)
HYDROXYCHLOROQUINE (1,388)
ADALIMUMAB (1,320)
TOCILIZUMAB (1,301)
LEFLUNOMIDE (1,181)
INFLIXIMAB (855)
SULFASALAZINE (849)
RITUXIMAB (600)
Which TOFACITINIB Alternatives Have Lower Red blood cell sedimentation rate abnormal Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN